abstract |
The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme. The present invention also relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 enzymes for the treatment of non-insulin-dependent type II diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome and Use in other diseases and conditions mediated by hormone action. |